Literature DB >> 10776791

Molecular, genetic and epidemiologic studies on selective complete C1q deficiency in Turkey.

A I Berkel1, E Birben, C Oner, R Oner, M Loos, F Petry.   

Abstract

Selective complete C1q deficiencies (SCDC1q) of the complement component C1q are rare genetic disorders with high prevalence of lupus-erythematosus-like symptoms and recurrent infections. Among the 41 published cases from 23 families, 10 derive from 6 Turkish families. One particular mutation leading to a stop codon in the C1q A gene was first identified in members of a Gypsy family from the Slovac Republic. Later the same mutation has been found in all cases in four SCDC1q families from Turkey suggesting that one particular defective allele may be present in the populations of Southeastern Europe and Turkey. This study was undertaken to investigate the frequency of C-->T mutation in exon II of C1qA gene in Turkish population by using allele-specific polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP). Among the 1544 patients from 15 pediatric departments and an additional 89 SLE patients of various ages no C1qA gene mutation was found. There were 43 heterozygous and 4 homozygous mutations in 161 family members or relatives investigated from the 4 families known with SCDC1q. Among the 223 inhabitants who were nonrelative to the 3 SCDC1q families living in the same village were screened for mutation and one heterozygous individual was observed. Although this mutant allele appears to be at a low prevalence in the population tested, individuals with recurrent infections or symptoms of lupus erythematosus-like syndrome should be tested for this mutation to rule out this type of C1q deficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10776791     DOI: 10.1016/S0171-2985(00)80089-3

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

1.  Common silent mutations in all types of hereditary complement C1q deficiencies.

Authors:  Franz Petry; Michael Loos
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

2.  Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus.

Authors:  Sagar Bhattad; Amit Rawat; Anju Gupta; Deepti Suri; Ravinder Garg; Martin de Boer; Taco W Kuijpers; Surjit Singh
Journal:  J Clin Immunol       Date:  2015-11-13       Impact factor: 8.317

3.  Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity.

Authors:  M Zirngibl; B G Fürnrohr; C Janko; L E Munoz; R E Voll; C D Gregory; G Schett; M Herrmann
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

4.  Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Natalia Umetsu; Adriana A Jesus; Silvia Y Bando; Clovis A Silva; Magda Carneiro-Sampaio
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

Review 5.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

6.  Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.

Authors:  Shuhong Chi; Yunxia Yu; Juan Shi; Yurong Zhang; Jijuan Yang; Lijuan Yang; Xiaoming Liu
Journal:  Dis Markers       Date:  2015-10-13       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.